SHARE:  

Member Login

Join AHPA

SCIENCE ALERT

The American Herbal Products Association (AHPA) distributes scientific news and published research about herbs and botanicals as Science Alerts. The information presented in Science Alerts represents the views and opinions of the original authors of the content and does not necessarily represent the views or opinions of AHPA. Distribution of scientific news and published research about herbs and botanicals as a Science Alert does not constitute AHPA endorsement of the content. Please direct any questions about Science Alerts to communications@ahpa.org.

Effects of curcumin/turmeric supplementation on liver function in adults: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials

June 2023

Complementary Therapies in Medicine

DOI: https://doi.org/10.1016/j.ctim.2023.102952


Abstract


Introduction

Liver conditions are major burdens upon health systems around the world. Turmeric /curcumin is believed to possess therapeutic features in ameliorating various metabolic disorders. In this systematic review and meta-analysis of the randomized controlled trials (RCTs), we examined the effect of turmeric/curcumin supplementation on some liver function tests (LFTs).


Methods

We comprehensively searched online databases (i.e. PubMed, Scopus, Web of Science, Cochrane Library, and Google Scholar) from inception up to October 2022. Final outcomes included aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT). Weighted mean differences (WMDs) were reported. In case of between-study heterogeneity, subgroup analysis was conducted. Non-linear dose-response analysis was carried out to detect the potential effect of dosage and duration. The registration code is CRD42022374871.


Results

Thirty-one RCTs were included in the meta-analysis. Turmeric/curcumin supplementation significantly reduced blood levels of ALT (WMD = −4.09 U/L; 95 % CI = −6.49, −1.70) and AST (WMD = −3.81 U/L; 95 % CI = −5.71, −1.91), but not GGT (WMD: −12.78 U/L; 95 % CI: −28.20, 2.64). These improvements, though statistically significant, do not ensure clinical effectiveness.


Conclusion

It seems that turmeric/curcumin supplementation might be effective in improving AST and ALT levels. However, further clinical trials are needed to examine its effect on GGT. Quality of the evidence across the studies was low for AST and ALT and very low for GGT. Therefore, more studies with high quality are needed to assess this intervention on hepatic health.

Subscribe

Latest News

Events

Contact Us

Upcoming AHPA Events

2023 AHPA Annual Fund Sponsors

Connect with AHPA

LinkedIn  Facebook  Instagram